漢宇集團(300403.SZ):控股股東石華山減持比例達1.05%
格隆匯12月22日丨漢宇集團(300403.SZ)公佈,公司於近日收到控股股東、實際控制人石華山出具的《股份減持情況告知函》,石華山在2020年9月17日至2020年12月21日期間,通過集中競價方式累計減持其直接持有的公司股份633.4401萬股,佔公司總股本的1.05%。
截至2020年12月21日,石華山直接持有公司股份約2.6366億股,並通過江門市江海區神韻商貿中心(有限合夥)間接持有公司股份1977.4249萬股,合計佔公司總股本的47.00%。其與一致行動人樑穎光通過直接及間接方式持有公司股份約2.8764億股,佔公司總股本的47.70%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.